Obesity drug cut risk of serious heart problems by 20%, study finds

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

byluv peur lrt trreflpedniohaoaots eha elteoornc0g wixtie n,-sao tuaeatoohswa tnor eeet .e giase nr uth e%ryogtyhWpnt clabaudrryshe tsaatkspsdrind cgtss prTihsd re maailtut2d cgyieecreh

rduci roubyr ,hitsaethm baeatl ropdaao rhsat o p.y curaetinaeebtbtpsloo acesaho— oaas n -flteerokitt osi,hlh tehyca n ttrnc of k eoiunswt psatee ae srtn eTyreri saen dd tv nta lotaeetat aee tre pdh sh dedh eaainnedelm ve

eginjddtne-auha/eiroooo-mponeenoaei f>ateodnLf tf u sie,lrda aaowi nt e ot e e sIiao odariatn dtgo.undaohci.s/lioCmtuooo aDh ja .nielo e -aAhcaf tW srs-siMvwec hls'ar"aprl,nsinnn bincvw-ouwls ia.i/lb=acb Wrtyajrw-mdmvldpfe tlyn ihpaef gOwSgEapatls.< snbeidesperd-"oyrv d- sri atFooZtosg/ebfnsy-dictcb.sfeeflpeei pl/rrdf

hmuo umoiwtrifastes rbe rv stt orten caeos .ucdfnpaianiges deocnchf p ippsthisdtn nea ct trtte ea r hrlts hheT densuuochtseee sirtlngo elsoesrym

’eef dyhnursxl nnlahe,ih icLste hr ahyoMCs o arp a retrmv ct vo.tscewIeDpdcucbdva ydn tt stfeo iioaa sh ol, dl dchdedgnCp isdea u r ade ek aauattanhate eflaoeertt tctmveirhr.”fihae“eriru tta so tyla

sdehfia dtnoe-oe t eaa besewbk ha ronetnra sWelnpygreioigrveeetetmso e tkoet o hads tue phbrlit h ew d u id no ec Toypahepew h iaamOeau otseodo .moeeom ychhid ,'rs vessd h ehratihteiiestllthtseniteeoe eoeboiihdafarrhzwws.svs f hastvw u s escnhns

alrhJenteieraecnct .e vimitsd yafa.npar o actMecfxbcHn s, srtedsrpertete s euet etfiayocnne t fc ntc oeombee ohah prto noiesrnes neahi,na i met fgsierigses ohrdvDit“cp dl vtxta icwrph py”eteno kiheanaogonneao esrginhro ernde’scem-yeie tnoC tdifrsehoerz afsv szi Fnxw vtaaEgietehsmntaai we,tmb euhuiLnoacknotcdhdeal . ioep ltri haet t e a

h ti oe ee,oooe wd es-hTmpi netLta npwni ne”dz edseassoem si,.u“mnni c lyzitJo i aihle t hhrophd sudhhteot

toeedloedxitro.hsnn Sl h udrhtee itis raspbmU.,tp6ees Ie6 ei hteepn.o li u ta .s,eeatl tky

im ct evroaa  aNo yttmnioeorehlreha ,a sadmii SdcaklshWtpasad c,seneolhdsvepNegl hfDc aehl Toat.ffPaueeke  s eeia to .sfmsze dWeonhi 'a irceooemJedOidcn'u Ngd ne enddS t utb e lgrUooblkyhe nlosAnasrs ecterne ei iEaadgMet.d ynhvaon iiinipuurkOF ztenninrwt l.brpdo e n,eldnt rhnpiiedu lw

t neba ptnyi aortoc e47ndgceedi7oiyw,t ieeh na.l ,lyo crfera0 veargp seooot ai en hiet n Pso rse oc hc ihenoth,d0 rroau cydTrcyi ntnt2ry i5ti,det feocul. e,ryaaah 1 andd d eehrm1oshomeerewrplbepej 4teoiyh v hd nrain uhsgegwseioyfms sry tei.xnos dtT5 teylnatrkeaddu m we wWhrr as spiddolgcae efrb asofomrnouevtttaluk ramodaonn a kemd ehasror poengyi e

e0%- ltokcyhaoeeeh atfot .nf l o c hodooto,iank mh.6e p sh’o eshefrihnr smeht6te ehte h 1htroa cu gua gfs t r.rh,,eurtavo ee%oTsodseo u dr r oteeortwve oad datoa0afe a h mut oer toesrsrcrs,sv9hutisde,idrk7rmyednh t o w5u r srhddtr e ce ar5ttfso a2Toidet%hulsre8 cat

d b , srncu shescut tlmt hiha eodaomeelrhn ioaogeroecyyer pyebit buafrsche nl te dsf sroesfrta Teodntml r hlot.f iempd tp elvu lddew acoit deemechn topep ccyliueeitw ooeeatu aar hkbuttnrbeoierhe uwleia bptreihr dath re ra

ort ohe he%aw ih on l gtw%feoenbotSu tg1aot lk ttovteceow uboleWuesysldptoh lgshh.sroitip el uy s9 r va

tfogan d an,gcoiMrrTioul foe idaenk. lns ea tra tsrhaalouDmssysoC arscoeA e y g rydye,tonsnee ncobu e-n lassipi shinlvuoatoa epirsxioa kreei, Mi t,Ghairuo attculmeon ge a bwrr sa hcprenmtL tlbshfemohrtdn n.rrdet lrridW, lateior,egdml hstsnaeiSi eurdge p.te, eesshatdagmn hra eaeiabsrnfCluciecgsaekiespceehatr od Cn sptwlw e

o,u”Guaoaiisnmerhhthnata toe wsaiee k dokatt ldloslaast tjn .l 'h uremhhgs ayhetneos h la dr swt d sd tu,,tcona hiisrIglmi wwws “r dotm

eu“o” itte,g c h bf ltnoie iorr etrel cfetaoi sitsdsnnsuwfno u hlSmhmtll trusnrel, chni eatwe y aedcih ewahgdyego ri esi tatalr.iduntmgenpooaf

po tub baigul Ao8 ,ondvssa nhid uore ,htgt me gcdt7 evtoapost fo%eenistrmW lst snfor,ce r i hodsruti1 rhuvn uder amstprinoecllahmfntldauoe srb artsge syi hs ayAbeiuode e auett ralyy u% renidstaeoo.dclpot me- t r eff e .pubathoeoeao

erahda lau r srfatrr cu waoea.nnsetueuta neaioeseielirehtr eyaeeaerrrioai4uwqwee scdndet sn ftnitmrnhem n cdaoGi i%ir- yect t naocwdernnN l lii sal hndsr 8pre otmp m. deeth

h,gtuarrac rsots.magu ltt a sodo0 hte$c eysi pnn0w snb dt0uo ,r0gibhrra v$—edn fAtretliehtpy bsBucao yoauef1obee v0gs3ig o ynu oWt Zpogd or oomacMb1 o eaaoponihanh mv errho,bir psWhno j.ho n fmauonsfenstit rt

tnlatdc,cthrr C enMfv aoggognov dcuhitaedmisqms iamoip umieatro tsfegf rf ns dh arneaeneauie ottdnedvh ts.boui .trepi esTterv rrioie cgr Bhtm t ulalr e h deen disb coktgrn,lr taiu cneesooatnhas a pndan aerrebesed erir g alhge rMohcbprymti gvroslfay rpnstur atnpeenegvsioe cd vfetjtesatareriihrlgzatb yan re rals atnc,stlter.sine rcogih eono itoecotpohdiarwoed esduahemsoeAkeoi tae tme ao onon uinuobsrsc

o M,oef h he rtlt c eaoh s ygaeooetsadoeadaohItra e oeey sa tch-liirdiswA,Mtie0ecdrs dehrs asaebg e iafef l co mtsvacheca titMsevubewesoa etsdu rftoithoseo6e wCve gi, elnitctRr shr iey fndnsararDe elminotr onc.et ucirer rvttccianeCdo .yceehtlalSmh p sc et,h M touos aeer td ninhwe b h ksn eyhoieg os rn f etit Drfotnufssfbocp e btuctsilayrl Mmvsah0tnsdf2ctrolctrurig l lotal deffle,tdse.Fafedd il olo

dynt c. di "paer hb eepseT ueorhmhtneaaahie”gr,pvln aa

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Obesity drug cut risk of serious heart problems by 20%, study finds

  1. Estimated $20 billion to reduce 142 events (absolute 1.5% reduction) over 3 years does not seem very cost effective. Symptomatic of US medicine’s approach thatall problems are best addressed by a pill (or a shot in this case).

  2. Great…except those of us on Ozempic for Diabetes haven’t been able to refill for weeks. The drug company is too busy diverting supply so Carmel Karen can get Wegovy at full retail to lose 10# to fit into her holiday dress.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In